Abstract
According to GCP, sponsors and organizations that take over sponsor responsibilities, are responsible for implementing a quality management system with written standard operating procedures (SOPs). Changes in the German Drug Law and Medical Device Act made these principles mandatory also for investigator-initiated trials, in which SOPs had been rarely used until 2000. This changed with the introduction of the (Coordinating) Centers for Clinical Trials as central service units for clinical trials at university hospitals all over Germany since 1999. They constituted a quality management working group which developed concerted SOPs for clinical trials with medicinal products and medical devices as well as SOP templates for trial sites considering the characteristics of academic structures. The SOPs described in this publication have become major instruments to enhance the quality of investigator-initiated trials and to ease the cooperation of (Coordinating) Centers for Clinical Trials.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
